Teen Pop Sensation Shares Personal Story to Inspire Others to Achieve Their

                               'Simple Wins'



    TARRYTOWN, N.Y., Aug. 6 /EMWNews/ -- Today, Nick Jonas, the youngest

member of the Jonas Brothers established his role as a diabetes ambassador

by launching a new partnership with Bayer Diabetes Care to provide young

people and their families with the motivation and support they need to help

simplify life with diabetes.



    At a press conference today in New York City, Nick and Bayer kicked off

their long-term partnership, with Bayer making an initial large donation to

the Change for the Children Foundation to support Nick's goal of helping

children with diabetes. The Foundation is a Jonas Brothers organization

that provides support to programs that motivate and inspire children to

face adversity with confidence, determination and a will to succeed. The

partnership will provide resources and information over the next few years

specifically designed for young people with diabetes to help them simplify

their lives and successfully manage their disease.



    Nick, diagnosed with type 1 diabetes at age 13, is passionate about

sharing his personal story because he knows so many young people like him

can feel alone and even embarrassed by the disease. It's important to Nick

to take what he's learned and what works for him and pass it along to

others who may be feeling the same way.



    "Nearly every day I hear from someone like me who says that I make them

feel it's OK to have diabetes and that's really cool that I can do that,"

said Nick Jonas. "I know I'm lucky because I have a family that encourages

me a lot. I want to give that same inspiration to other kids with diabetes,

and working with Bayer lets me do that."



    Bayer and Nick share a common goal of helping people with diabetes

simplify their lives by achieving "Simple Wins": small, everyday victories

for managing the disease that can lead to big differences over time. For

Nick, a Simple Win is about making other kids with diabetes feel like they

can live their dreams and have a positive outlook.



    "Nick is a deeply passionate role model for young people with diabetes

and their families, and Bayer shares in his dedication," said Sandra

Peterson, President of Bayer Diabetes Care. "Bayer believes Nick can play a

significant role in encouraging all people with diabetes, no matter how

young or old, to be proactive in managing their diabetes to live their

lives to the fullest."



    Through the partnership, young people with diabetes and their families

can log on to http://www.NicksSimpleWins.com, where they can check out more about

Nick's personal experiences. Nick will be blogging about his latest

activities, giving updates on chances to meet him in person and sharing

ideas on how to achieve Simple Wins. Also available to download is "A

Little Bit Longer," a new single released yesterday and the title track to

the Jonas Brothers' upcoming album. Nick wrote this song when he was having

a particularly hard day managing his diabetes and feels supported when his

fans sing along to the lyrics.



    "I'm so proud of Nick's incredibly positive attitude and his sense of

responsibility to give back to other people with diabetes," said Nick's

mom, Denise Jonas. She plans to be involved in the program, working with

her family to help provide information and encouragement to other families

living with diabetes.



    Diabetes is a disease where the body doesn't produce or properly use

insulin. Insulin is the hormone that converts sugar, starches and other

food into the energy needed to live. According to the Centers for Disease

Control, diabetes is one of the most common chronic diseases among children

in the United States. About 150,000 young people under 18 years of age have

diabetes.



    Type 1 diabetes, also called juvenile diabetes, is usually diagnosed in

children and young adults. With type 1 diabetes, your body makes little or

no insulin, which may result in many complications if glucose levels are

not controlled.



    Nick uses the new Bayer CONTOUR(R) meter to test how much glucose or

sugar is in his blood so he can determine how much insulin he needs as well

as to see how his treatment regimen is working. It's the first thing he

learned about managing his condition. CONTOUR Colors meters will be

available soon in Green Apple, Royal Purple and Graphite Gray -- to fit

everyone's individual style.



    "I check my blood sugar level up to 12 times a day so it's very

important that my meter fits with my lifestyle," said Nick. "My new Bayer

CONTOUR meter lets me personalize the settings when I need to test myself

before a meal or reminding me to check after a meal, for example, depending

on my schedule on a specific day."

    About Change for the Children Foundation



    The Change for the Children Foundation is a Jonas Brothers organization

that provides support to programs that motivate and inspire children to

face adversity with confidence, determination and a will to succeed. The

Jonas Brothers believe that the best people to help children are their

peers, and the foundation provides opportunities for kids to help other

kids who are a little less fortunate.



    "YOU Decide. YOU Donate." is a current initiative of The Change for the

Children Foundation. The Jonas Brothers have selected five charities and

are calling on kids to decide which one to support.



    D-Vision is Nick Jonas' part of the Change for the Children Foundation.

Its goal is to support people with diabetes and help raise money and

awareness to research a cure. http://www.changeforthechildren.org



    Bayer HealthCare, Diabetes Care



    Bayer HealthCare, Diabetes Care is a worldwide leader in diabetes,

supporting customers in 100 countries. Since the introduction of

CLINITEST(R) reagent tablets in 1941, Bayer has led the way in diabetes

care product innovation. The company changed the face of diabetes care in

1969 when it introduced the first portable blood glucose meter and test

strips. Bayer HealthCare further innovated diabetes management by being the

first company to introduce a suite of blood glucose monitors with No

Coding(TM) technology. The BREEZE(R)2 and CONTOUR(R) blood glucose

monitoring systems offer people with diabetes an unparalleled choice in

diabetes management systems. The Arthritis Foundation in the United States

and the Arthritis Society of Canada each granted Ease-of Use Commendation

to the BREEZE(R)2 meter. BREEZE(R) represents the first time a blood

glucose meter has been recognized as easy to use for arthritis sufferers.



    In July 2006, Bayer Diabetes Care acquired Metrika Inc., maker and

manufacturer of A1CNow+, a meter-based diabetes monitoring system for

measurement of A1C (glycated hemoglobin) an important indicator of long

term blood sugar control. Bayer HealthCare, Diabetes Care global

headquarters is located in Tarrytown, New York, in the United States and

operates as part of Bayer HealthCare LLC, a member of the worldwide Bayer

HealthCare group. http://www.bayerdiabetes.com/us



    Bayer HealthCare



    Bayer HealthCare, a subsidiary of Bayer AG, is one of the world's

leading, innovative companies in the healthcare and medical products

industry and is based in Leverkusen, Germany. The company combines the

global activities of the Animal Health, Consumer Care, Diabetes Care and

Pharmaceuticals divisions. The pharmaceuticals business operates under the

name Bayer Schering Pharma AG. Bayer HealthCare's aim is to discover and

manufacture products that will improve human and animal health worldwide.



    This news release contains forward-looking statements based on current

assumptions and forecasts made by Bayer Group management. Various known and

unknown risks, uncertainties and other factors could lead to material

differences between the actual future results, financial situation,

development or performance of the company and the estimates given here.

These factors include those discussed in our public reports filed with the

Frankfurt Stock Exchange and with the U.S. Securities and Exchange

Commission (including our Form 20-F). The company assumes no liability

whatsoever to update these forward-looking statements or to inform them to

future events or developments.